Un Umuthi wokugoma wokuhlola umalaleveva, i- "Mosquirix", uthole imvume ye-European Medicines Agency ngoLwesihlanu. Owokuqala emhlabeni wezokwelapha noma ngabe i-serum, okwamanje, isebenza ngempumelelo kuphela.
Lezi yizindaba ezinhle zokuqala futhi ezimnandi kakhulu. NgoLwesihlanu ngoJulayi 24, umuthi wokugomela umalaleveva uthole "umbono omuhle" ovela e-European Medicines Agency (EMA). Ibizwa nge- “Mosquirix” futhi yadalwa yi-giant eyenza imithi i-GlaxoSmithKline (GSK) ukuvikela izingane ezincane, ikakhulu e-Afrika, engcupheni enkulu yalesi sifo. Lesi yisikhathi sokuqala ukuthi umuthi wokugoma wenzelwe ukulwa nesimuncagazi (iPlasmodium falciparum, igciwane likamalaleveva) hhayi igciwane noma amagciwane.
>> Ukugxila: “I-Malaria ibulala ingane njalo ngemizuzwana engu-30"
Uyayithanda iwebhusayithi?
Finyelela kukho konke okuqukethwe kwethu kwe-Premium. Ama-athikili nama-ebook angaphezu kuka-2000